Print Email this page China Practice  

Pryor Cashman is a full-service firm uniquely equipped to provide legal advice and offer practical solutions to China-based companies seeking to conduct business in the U.S or to access the U.S. capital markets. In order to serve the legal needs of our China-based clients, our China Practice brings together the expertise and capabilities of various practice groups, such as Corporate, Litigation, Real Estate, Tax and Banking, and includes attorneys versed in Chinese culture and language.

A key area of our China Practice is the representation of publicly-traded China-based companies with regard to their reporting obligations to the U.S. Securities and Exchange Commission (SEC), corporate governance and financing transactions, and the representation of privately-held China-based companies that are in earlier stages of becoming a public company, whether by initial public offering (IPO), reverse merger, or acquisition by a “special purpose acquisition corporation” (SPAC).  

In our representation of our China-based clients, we strive to contribute significant value by providing high-quality, personalized and cost-effective legal services. In transactional matters, we add further value by making available our key relationships with non-legal advisors that focus on meeting the needs of China-based companies, including accounting firms, investor relations firms, bankers and placement agents. 

Representative matters handled by our China Practice include:

• Serving as SEC and corporate counsel to China Green Agriculture, Inc. (Ticker: CGA), a NYSE-listed maker of fertilizer and other agricultural products based in Shaanxi province and advising China Green on a $25 million registered direct public offering and its listing on the NYSE 
• Representing a leading China-focused investment bank on several underwritten and private offerings by China-based companies
• Serving as SEC and corporate counsel to China Medicine Corporation (Ticker: CHME), an OTCBB-traded maker of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines and other products based in Guangzhou province, and advising China Medicine on a $70 million private equity financing
• Serving as SEC and corporate counsel for BEFUT International Co., Ltd. (Ticker: BFTI), an OTCBB-traded maker of electrical and specialty wire and cable products based in Dalian City, Liaoning province
• Serving as SEC and corporate counsel to China Shenghuo Pharmaceutical Holdings, Inc.  (Ticker: KUN), a NYSE AMEX-listed maker of pharmaceutical, nutritional supplement and cosmetic products based in Yunnan province
• Serving as corporate counsel to Zhongpin Inc. (Ticker: HOGS), a NASDAQ-listed meat processing and distribution company based in Henan province, and advised Zhongpin on a $60 million underwritten public offering and various private investment in public equity (PIPEs) financing transactions involving proceeds of over $75 million
• Represented Agfeed Industries, Inc. (Ticker: FEED), a NASDAQ-listed manufacturer of animal feed products based in Jianxgi province, on its $75 million public offering
• Assisted both Shiner International, Inc. (Ticker: BEST), a NASDAQ-listed manufacturer of packaging materials based in Hainan province, and Zhongpin Inc. with their listing applications for the NASDAQ Global Select or Capital Markets and the preparation and filing with the SEC of their resale registration statements
• Representing a publicly-traded, China-based company in a complex securities class action lawsuit instituted in the U.S.
• Advising several privately-held China-based companies on their private placement financing transactions and counseling such companies on becoming U.S. public companies

Please click on the appropriate link to download Pryor Cashman's China Practice brochure in either Mandarin or English.